DK3408292T3 - Splittede inteiner med ganske særlig splejseaktivitet - Google Patents
Splittede inteiner med ganske særlig splejseaktivitet Download PDFInfo
- Publication number
- DK3408292T3 DK3408292T3 DK17745022.8T DK17745022T DK3408292T3 DK 3408292 T3 DK3408292 T3 DK 3408292T3 DK 17745022 T DK17745022 T DK 17745022T DK 3408292 T3 DK3408292 T3 DK 3408292T3
- Authority
- DK
- Denmark
- Prior art keywords
- inteins
- spliced
- splicing activity
- special splicing
- special
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/92—Fusion polypeptide containing a motif for post-translational modification containing an intein ("protein splicing")domain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662288661P | 2016-01-29 | 2016-01-29 | |
| PCT/US2017/015455 WO2017132580A2 (en) | 2016-01-29 | 2017-01-27 | Split inteins with exceptional splicing activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3408292T3 true DK3408292T3 (da) | 2023-06-12 |
Family
ID=59398921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17745022.8T DK3408292T3 (da) | 2016-01-29 | 2017-01-27 | Splittede inteiner med ganske særlig splejseaktivitet |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11142550B2 (https=) |
| EP (2) | EP4234689A3 (https=) |
| JP (1) | JP7290305B2 (https=) |
| CN (1) | CN108884154A (https=) |
| AU (1) | AU2017211395B2 (https=) |
| CA (1) | CA3051195A1 (https=) |
| DK (1) | DK3408292T3 (https=) |
| ES (1) | ES2949163T3 (https=) |
| FI (1) | FI3408292T3 (https=) |
| HU (1) | HUE062276T2 (https=) |
| PL (1) | PL3408292T3 (https=) |
| PT (1) | PT3408292T (https=) |
| SI (1) | SI3408292T1 (https=) |
| WO (1) | WO2017132580A2 (https=) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6261500B2 (ja) | 2011-07-22 | 2018-01-17 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ヌクレアーゼ切断特異性の評価および改善 |
| CA2909733C (en) | 2013-04-18 | 2023-10-17 | Fondazione Telethon | Effective delivery of large genes by dual aav vectors |
| US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| WO2016022363A2 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| EP3322800A4 (en) | 2015-07-13 | 2019-05-01 | University of Utah Research Foundation | PROCESS FOR THE PRODUCTION OF RED BLOOD BODIES AND BLOOD PLATES IN VITRO AND USES THEREOF |
| JP7109784B2 (ja) | 2015-10-23 | 2022-08-01 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 遺伝子編集のための進化したＣａｓ９蛋白質 |
| ES2949163T3 (es) * | 2016-01-29 | 2023-09-26 | Univ Princeton | Inteínas divididas con actividad de corte y empalme excepcional |
| KR102547316B1 (ko) | 2016-08-03 | 2023-06-23 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| EP3526320A1 (en) * | 2016-10-14 | 2019-08-21 | President and Fellows of Harvard College | Aav delivery of nucleobase editors |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| JP2020510038A (ja) | 2017-03-09 | 2020-04-02 | プレジデント アンド フェローズ オブ ハーバード カレッジ | がんワクチン |
| JP2020510439A (ja) | 2017-03-10 | 2020-04-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | シトシンからグアニンへの塩基編集因子 |
| CA3057192A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| WO2019023680A1 (en) | 2017-07-28 | 2019-01-31 | President And Fellows Of Harvard College | METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| KR20250107288A (ko) | 2017-10-16 | 2025-07-11 | 더 브로드 인스티튜트, 인코퍼레이티드 | 아데노신 염기 편집제의 용도 |
| WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| EP3797160A1 (en) | 2018-05-23 | 2021-03-31 | The Broad Institute Inc. | Base editors and uses thereof |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| AU2019316094B2 (en) | 2018-08-03 | 2026-02-19 | Beam Therapeutics Inc. | Multi-effector nucleobase editors and methods of using same to modify a nucleic acid target sequence |
| US11530245B2 (en) * | 2018-08-31 | 2022-12-20 | Washington University | Split intein mediated polymerization and production of mussel foot adhesive protein materials |
| KR20210055733A (ko) | 2018-09-07 | 2021-05-17 | 빔 테라퓨틱스, 인크. | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 |
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| AU2019360372B2 (en) * | 2018-10-15 | 2026-02-26 | Fondazione Telethon | Intein proteins and uses thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| LU101118B1 (en) * | 2019-02-06 | 2020-08-06 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Method for detecting a specific splice event of a gene of interest |
| WO2020168122A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| JP7657726B2 (ja) | 2019-03-19 | 2025-04-07 | ザ ブロード インスティテュート，インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| CN110714020B (zh) * | 2019-05-22 | 2021-08-03 | 北京理工大学 | 一种高效简便纯化蛋白的方法 |
| WO2021016075A1 (en) | 2019-07-19 | 2021-01-28 | Flagship Pioneering Innovations Vi, Llc | Recombinase compositions and methods of use |
| CA3152679A1 (en) * | 2019-08-28 | 2021-03-04 | The Trustees Of Princeton University | Atypical split inteins and uses thereof |
| US20220332757A1 (en) * | 2019-09-09 | 2022-10-20 | Wuhan Yzy Biopharma Co., Ltd. | Split intein and preparation method for recombinant polypeptide using the same |
| EP4034138A4 (en) | 2019-09-27 | 2024-07-31 | Beam Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS |
| KR20220070481A (ko) * | 2019-10-01 | 2022-05-31 | 유타대학연구재단 | 순환 종양 세포를 표적화하기 위한 혈소판 조작 방법 |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| GB201917046D0 (en) * | 2019-11-22 | 2020-01-08 | Ge Healthcare Bioprocess R&D Ab | Improved protein production |
| IL296024A (en) | 2020-03-04 | 2022-10-01 | Flagship Pioneering Innovations Vi Llc | Methods and compositions for modulating a genome |
| CN111235174A (zh) * | 2020-03-11 | 2020-06-05 | 梦芊科技知识产权有限公司 | 利用枯草芽孢杆菌和核酸内切酶制备人碱性成纤维细胞生长因子 |
| EP3885440A1 (en) * | 2020-03-26 | 2021-09-29 | Splicebio, S.L. | Split inteins and their uses |
| DE112021002672T5 (de) | 2020-05-08 | 2023-04-13 | President And Fellows Of Harvard College | Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz |
| US20230227508A1 (en) | 2020-06-12 | 2023-07-20 | Massachusetts Institute Of Technology | Split intein-based selection for peptide binders |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| CA3216901A1 (en) * | 2021-05-12 | 2022-11-17 | Cytiva Bioprocess R&D Ab | Improved protein purification |
| CN113735941B (zh) * | 2021-08-13 | 2024-01-30 | 江南大学 | 一种蛋白纯化方法及其应用 |
| KR102663243B1 (ko) * | 2021-08-30 | 2024-05-03 | 국립순천대학교산학협력단 | 트립신 특이적 형광 프로브 및 이의 용도 |
| JP2024533311A (ja) | 2021-09-08 | 2024-09-12 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | ゲノムを調節するための方法及び組成物 |
| WO2023081714A1 (en) * | 2021-11-02 | 2023-05-11 | Cornell University | Intein systems and uses thereof |
| WO2023229029A1 (ja) * | 2022-05-26 | 2023-11-30 | 国立大学法人山形大学 | ヘテロダイマータンパク質の製造方法、ダイマータンパク質、モノマータンパク質、および標的反応性のヘテロダイマータンパク質のスクリーニング方法 |
| CA3267375A1 (en) * | 2022-09-26 | 2024-04-04 | Beam Therapeutics Inc. | SYNTHETIC POLYPEPTIDES AND THEIR USES |
| EP4612166A1 (en) * | 2022-11-01 | 2025-09-10 | Memorial Sloan-Kettering Cancer Center | Intein-based sorting system and modular chimeric polypeptides |
| WO2024170051A1 (en) * | 2023-02-13 | 2024-08-22 | Kutzner Christoph | Fusion polypeptides for manufacturing of cyclic peptides |
| KR20260040523A (ko) | 2023-06-11 | 2026-03-24 | 리제너론 파아마슈티컬스, 인크. | 환형화 항체 분자 |
| AU2024338787A1 (en) | 2023-09-04 | 2026-03-19 | Splicebio, Sl | Use of split intein for the treatment of scn1a associated disease |
| WO2025153705A1 (en) | 2024-01-18 | 2025-07-24 | Splicebio, Sl | Use of split intein for the treatment of myo7a-associated disease |
| WO2025194124A1 (en) | 2024-03-14 | 2025-09-18 | Tessera Therapeutics, Inc. | Modified st1cas9 guide nucleic acids |
| WO2026013288A1 (en) | 2024-07-12 | 2026-01-15 | Splicebio, Sl | Split intein for use in the treatment of cep290-associated disease |
| WO2026057767A1 (en) | 2024-09-13 | 2026-03-19 | Splicebio, Sl | Use of split intein for the treatment of abca3-associated disease |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2761006B1 (en) * | 2011-09-28 | 2016-12-14 | Zera Intein Protein Solutions, S.L. | Split inteins and uses thereof |
| DK3431497T3 (da) * | 2012-06-27 | 2022-10-10 | Univ Princeton | Spaltede inteiner, konjugater og anvendelser deraf |
| EP2943573A1 (en) * | 2013-01-11 | 2015-11-18 | The Texas A&M University System | Intein mediated purification of protein |
| ES2949163T3 (es) * | 2016-01-29 | 2023-09-26 | Univ Princeton | Inteínas divididas con actividad de corte y empalme excepcional |
-
2017
- 2017-01-27 ES ES17745022T patent/ES2949163T3/es active Active
- 2017-01-27 AU AU2017211395A patent/AU2017211395B2/en active Active
- 2017-01-27 CN CN201780021267.0A patent/CN108884154A/zh active Pending
- 2017-01-27 DK DK17745022.8T patent/DK3408292T3/da active
- 2017-01-27 CA CA3051195A patent/CA3051195A1/en active Pending
- 2017-01-27 HU HUE17745022A patent/HUE062276T2/hu unknown
- 2017-01-27 WO PCT/US2017/015455 patent/WO2017132580A2/en not_active Ceased
- 2017-01-27 SI SI201731373T patent/SI3408292T1/sl unknown
- 2017-01-27 PT PT177450228T patent/PT3408292T/pt unknown
- 2017-01-27 FI FIEP17745022.8T patent/FI3408292T3/fi active
- 2017-01-27 EP EP23168286.5A patent/EP4234689A3/en active Pending
- 2017-01-27 US US16/073,602 patent/US11142550B2/en active Active
- 2017-01-27 EP EP17745022.8A patent/EP3408292B1/en active Active
- 2017-01-27 PL PL17745022.8T patent/PL3408292T3/pl unknown
- 2017-01-27 JP JP2018539361A patent/JP7290305B2/ja active Active
-
2021
- 2021-06-30 US US17/363,698 patent/US12297472B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017132580A3 (en) | 2017-09-14 |
| ES2949163T3 (es) | 2023-09-26 |
| US20200055900A1 (en) | 2020-02-20 |
| EP3408292A4 (en) | 2019-09-18 |
| JP7290305B2 (ja) | 2023-06-13 |
| US11142550B2 (en) | 2021-10-12 |
| JP2019506163A (ja) | 2019-03-07 |
| CA3051195A1 (en) | 2017-08-03 |
| PT3408292T (pt) | 2023-07-19 |
| SI3408292T1 (sl) | 2023-09-29 |
| HUE062276T2 (hu) | 2023-10-28 |
| AU2017211395A1 (en) | 2018-09-06 |
| EP4234689A3 (en) | 2023-09-13 |
| AU2017211395B2 (en) | 2024-04-18 |
| PL3408292T3 (pl) | 2023-10-02 |
| EP3408292B1 (en) | 2023-04-26 |
| EP3408292A2 (en) | 2018-12-05 |
| CN108884154A (zh) | 2018-11-23 |
| WO2017132580A2 (en) | 2017-08-03 |
| US20210371467A1 (en) | 2021-12-02 |
| EP4234689A2 (en) | 2023-08-30 |
| US12297472B2 (en) | 2025-05-13 |
| FI3408292T3 (fi) | 2023-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3408292T3 (da) | Splittede inteiner med ganske særlig splejseaktivitet | |
| DK3349580T3 (da) | Hepatitis b kerneproteinmodulatorer | |
| PL3491450T3 (pl) | Naświetlanie linią laserową | |
| DK3292141T3 (da) | Fusionsproteiner | |
| DK3532768T3 (da) | Pladslys | |
| EP3302225A4 (en) | CONDUCTIVE OPTICAL ELEMENT | |
| EP3574547C0 (en) | WAVEGUIDE ASSEMBLY | |
| EP3323609A4 (en) | OPTICAL LAMINATE | |
| EP3333619A4 (en) | OPTICAL MODULATOR | |
| EP3384346A4 (en) | ELECTROCHROMIC ELEMENT | |
| DK3163339T3 (da) | Polariseringsbevarende multikernefiber | |
| EP3553214A4 (en) | ELECTRET FIBER SHEET | |
| DK3246736T3 (da) | Optisk fiber | |
| EP3457205A4 (en) | ELECTROCHROMIC ELEMENT | |
| EP3646319A4 (en) | VOICE INTERFACE PURCHASING SYSTEM | |
| EP3402856A4 (en) | OPTICAL ADHESIVE | |
| DK3687825T3 (da) | Optisk sikkerhedselement | |
| EP3470898A4 (en) | OPTICAL CONNECTOR | |
| DK3435126T3 (da) | Optisk fiber | |
| EP3546997A4 (en) | OPTICAL FIBER FUSION SPLICE DEVICE | |
| EP3540496A4 (en) | MOBILE REFLECTIVE ELEMENT | |
| DE112015006555A5 (de) | Positioniersystem mit wicklungsanordnung | |
| EP3519383C0 (en) | RETINOID DERIVATIVES WITH ANTITUMOR ACTIVITY | |
| EP3467557A4 (en) | OPTICAL CONNECTOR | |
| EP3446165A4 (en) | OPTICAL CONNECTOR |